» Articles » PMID: 37959679

In Vitro Antifungal Activity of Selected Essential Oils Against Drug-Resistant Clinical Spp. Strains

Overview
Journal Molecules
Publisher MDPI
Specialty Biology
Date 2023 Nov 14
PMID 37959679
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Treatment options for aspergillosis include amphotericin B (AMB) and azole compounds, such as itraconazole (ITZ). However, serious side effects related to these antifungal agents are increasingly evident, and resistance continues to increase. Currently, a new trend in drug discovery to overcome this problem is represented by natural products from plants, or their extracts. Particularly, there is a great interest in essential oils (EOs) recognized for their antimicrobial role towards bacteria, fungi and viruses.

Methods: In this study, we evaluated the antifungal activity of eleven commercial EOs-clove, eucalyptus, geranium, hybrid lavender, lavender, lemon, lemongrass, neroli, oregano, tea tree and red red thyme-in comparison with AMB and ITZ against , and clinical isolates. Antifungal activity was determined by broth microdilution method, agar diffusion technique, fungistatic and fungicidal activities and vapor contact assay.

Results: Gas chromatography-mass spectrometry analysis displayed two groups of distinct biosynthetical origin: monoterpenes dominated the chemical composition of the most oils. Only two aromatic compounds (eugenol 78.91% and eugenyl acetate 11.64%) have been identified as major components in clove EO. Lemongrass EO exhibits the strongest antimicrobial activity with a minimum inhibitory concentration of 0.56 mg/mL and a minimum fungicidal concentration of 2.25-4.5 mg/mL against spp. strains. Clove and geranium EOs were fairly effective in inhibiting spp. growth.

Conclusions: These results demonstrate the antimicrobial potential of some EOs and support the research of new alternatives or complementary therapies based on EOs.

Citing Articles

Natural Inhibitory Treatment of Fungi-Induced Deterioration of Carbonate and Cellulosic Ancient Monuments: Isolation, Identification and Simulation of Biogenic Deterioration.

El-Sayed M, Alharbi M, Elsehemy I, Haggag W, Refaat B, Ali S J Microbiol Biotechnol. 2024; 34(10):2049-2069.

PMID: 39263788 PMC: 11540613. DOI: 10.4014/jmb.2404.04032.


Synergistic Effect of Essential Oils and Antifungal Agents in Fighting Resistant Clinical Isolates of .

Cavallo L, Menotti F, Roana J, Costa C, Longo F, Pagano C Pharmaceutics. 2024; 16(7).

PMID: 39065654 PMC: 11279409. DOI: 10.3390/pharmaceutics16070957.

References
1.
Roana J, Mandras N, Scalas D, Campagna P, Tullio V . Antifungal Activity of Essential Oil (TTO) and Its Synergy with Itraconazole or Ketoconazole against . Molecules. 2021; 26(2). PMC: 7830555. DOI: 10.3390/molecules26020461. View

2.
Gupta A, Venkataraman M . Antifungal resistance in superficial mycoses. J Dermatolog Treat. 2021; 33(4):1888-1895. DOI: 10.1080/09546634.2021.1942421. View

3.
Pawar V, Thaker V . In vitro efficacy of 75 essential oils against Aspergillus niger. Mycoses. 2006; 49(4):316-23. DOI: 10.1111/j.1439-0507.2006.01241.x. View

4.
Rajkowska K, Nowicka-Krawczyk P, Kunicka-Styczynska A . Effect of Clove and Thyme Essential Oils on Biofilm Formation and the Oil Distribution in Yeast Cells. Molecules. 2019; 24(10). PMC: 6572016. DOI: 10.3390/molecules24101954. View

5.
Merad Y, Derrar H, Belmokhtar Z, Belkacemi M . Genus and Its Various Human Superficial and Cutaneous Features. Pathogens. 2021; 10(6). PMC: 8224566. DOI: 10.3390/pathogens10060643. View